Please assess the completion status of the following clinical trial:

Trial Title: Medtronic Minimed Overnight Closed-Loop System

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~To be eligible for the study, a subject must meet the following criteria:~* Clinical diagnosis of type 1 diabetes and using daily insulin therapy for at least one year and a Medtronic insulin infusion pump for at least 3 months The diagnosis of type 1 diabetes is based on the investigator's judgment; C peptide level and antibody determinations are not required.~* Age 10.0 - 35 years~Exclusion Criteria:~The presence of any of the following is an exclusion for the study:~* Diabetic ketoacidosis in the past month~* Hypoglycemic seizure or loss of consciousness in the past 3 months~* History of seizure disorder (except for hypoglycemic seizure)~* History of any heart disease including coronary artery disease, heart failure, or arrhythmias~* Cystic fibrosis~* Current use of oral/inhaled glucocorticoids, beta-blockers or other medications, which in the judgment of the investigator would be a contraindication to participation in the study.~* History of ongoing renal disease (other than microalbuminuria).~* Medical or psychiatric condition that in the judgment of the investigator might interfere with the completion of the protocol such as:~  * Inpatient psychiatric treatment in the past 6 months~ * Uncontrolled adrenal disorder~ * Abuse of alcohol~* Pregnancy

- Gender: ALL
- Minimum Age: 10 Years
- Maximum Age: 35 Years
- Healthy Volunteers: f

Study Arms:
- Inpatient overnight (Type: EXPERIMENTAL): Participants in this group will have an overnight evaluation to test safety of the closed-loop system therapy device.
- Summer Camp Session (Type: EXPERIMENTAL): Participants in this group will receive either the sensor augmented pump or the close loop controller on the first night, then alternated treatment type each night for the duration of the study.

Based on this trial design, predict the completion outcome and termination type (if applicable).